Ophthotech Corporation IPO Research Information

Ophthotech Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Ophthotech Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Ophthotech Corporation	OPHT -	$16.00-$19.00	$22.00	$23.06	2.28 million	9/25/2013
Underwriter(s): Morgan Stanley, J.P. Morgan
Co-Manager(s): Leerink Swann, Stifel
Industry: Health Care
Filing(s): Filed 2013-08-15

Ophthotech Corporation Quote & Chart - Click for current quote - OPHT

About Ophthotech Corporation (adapted from Ophthotech Corporation prospectus):
They are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the eye.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "OPHT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.